Company Filing History:
Years Active: 2002-2006
Title: The Innovative Contributions of Tobias Hildebrandt
Introduction
Tobias Hildebrandt is a notable inventor based in Reutlingen, Germany. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 2 patents, his work focuses on the determination of tumoricidal potential in human cells.
Latest Patents
Hildebrandt's latest patents include a process for determining the tumoricidal potential of a sample using a nucleic acid that is downregulated in human tumor cells. This process analyzes a cancer cell-containing test sample against a second sample from non-tumor cells to assess the potential for tumor development and progression. His other patent involves a nucleic acid molecule that is upregulated in metastatic human tumor cells, which is capable of inducing tumor progression and metastasis. This innovation provides a method for determining whether a tumor sample has metastatic potential.
Career Highlights
Throughout his career, Tobias Hildebrandt has worked with prominent companies in the healthcare sector, including Roche Diagnostics GmbH and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in cancer research.
Collaborations
Hildebrandt has collaborated with esteemed colleagues such as Ulrich Weidle and Goosen Van Muijen. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Tobias Hildebrandt's work exemplifies the impact of innovation in the field of cancer research. His patents not only advance scientific understanding but also hold the potential for significant improvements in cancer diagnostics and treatment.